Miguel Tejada received a 105-game suspension from Major League baseball after testing positive for amphetamines for a second and third time this year. The suspension would run through the first 65 games of the 2014 season, which may simply push the 39-year-old Tejada into retirement instead.
On the heels of that news, Twins starter Mike Pelfrey talked with Mike Berardino of the St. Paul Pioneer Press about his own legal, by-the-book use of Adderall to treat his ADHD. You should read the whole article here, but here is an illuminating snippet:
“When I don’t take my Adderall, my mind, my thoughts are just all over the place,” he said. “When I’m taking it, I’m able to focus on one task and able to do one thing instead of (having) 20 different things pop in your head. It definitely helps.”
Without an attention deficit disorder or ADHD diagnosis, Adderall could give a player additional energy, Pelfrey said.
“When you don’t need it, it acts like a true amphetamine,” he said. “I don’t get all amped up on it. I’m probably more laid back when I’m on it. My thought process is toned down to one thing instead of 20 different things. Without it I’m pretty hyperactive and running around.”
Though it is easy to look at Pelfrey’s 5.26 ERA and snicker, it can be tough to muster the energy to play at peak athletic form on a day-in, day-out basis over a six-month span, which is why more and more players have been testing positive for amphetamine use in recent years rather than steroids.
Former Colorado Rockies outfielder Ryan Spilborghs wrote a column earlier this year suggesting that Major League Baseball could reduce the need for players to rely on performance-enhancing drugs by expanding rosters and putting a cap on the maximum amount of games in which a player can play. Of course, the issue is complex enough that a couple tweaks to the rules won’t fix the issue, but it does show that the onus is not just on the players.
Free agent right-hander Tim Lincecum isn’t ready to hang up his cleats just yet. At least, that’s the word from Lincecum’s agent, Rick Thurman, who says the 32-year-old is still “throwing and getting ready for the season” (via Andrew Baggarly of the San Jose Mercury News).
Lincecum may not be ready to enter retirement, but another quote from Thurman suggests that he’ll be picky about where he pitches next. He doesn’t appear open to pitching overseas, and despite not having a contract for 2017 (or even any serious suitors), the right-hander is set on pitching in the big leagues this year. Whether or not he’s willing to take a bullpen role to do so remains to be seen.
While Baggarly predicts some interest in the veteran righty, there’s not much in Lincecum’s recent history to inspire faith in him as a starter, or even a reliever. He picked up a one-year, $2.5 million contract with the Angels following his hip surgery in 2015, and went 2-6 in 2016 with a 9.16 ERA, 5.4 BB/9 and 7.5 SO/9 over 38 1/3 innings. At this point, a minor league contract seems like the surest path back to major league success, though he’s unlikely to find an open spot on the Giants’ or Angels’ rosters anytime soon.
Free agent right-hander Jeff Manship has reportedly signed with the NC Dinos of the Korea Baseball Organization, according to FanRag Sports’ Jon Heyman. The righty was non-tendered by the Indians in December.
Manship, 32, completed his second season with Cleveland in 2016. He delivered a 3.12 ERA, 4.6 BB/9 and 7.5 SO/9 rate over 43 1/3 innings, a slight decline after posting an 0.92 ERA with the club the year before. During eight years in the major leagues, Manship carries a 4.82 career ERA, 3.6 BB/9 and 6.4 SO/9 in multiple stints with the Twins, Rockies, Phillies and Indians.
The right-hander will be joined by fellow MLB transplants Eric Hacker and Xavier Scruggs, each of whom took one-year deals with the Dinos last month. Steve Adams of MLB Trade Rumors notes that each KBO team is allowed up to three foreign players, so Manship will round out the trio when he joins the roster. Any salary terms have yet to be disclosed.